24 HR mirabegron 25 MG Extended Release Oral Tablet
- RxCUI
- 1300791
- RxNorm name
- 24 HR mirabegron 25 MG Extended Release Oral Tablet
- Display name
- 24 HR mirabegron 25 MG Extended Release Oral Tablet
- Full name
- 24 HR mirabegron 25 MG Extended Release Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mirabegron | MIRABEGRON | REMEDYREPACK INC. | b71b939e-8cb1-492c-8311-28f75dc4c682 | 2026-04-27 | Warnings, Adverse reactions | 1300791 |
| Mirabegron | MIRABEGRON | Amneal Pharmaceuticals NY LLC | e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 | 2026-03-26 | Warnings, Adverse reactions | 1300791 |
| MIRABEGRON | MIRABEGRON | Lupin Pharmaceuticals, Inc. | d22d3d12-8466-46db-bc19-d13e87c6115c | 2025-12-24 | Warnings, Adverse reactions | 1300791 |
| Mirabegron | MIRABEGRON | Qilu Pharmaceutical Co., Ltd. | 98247602-29b9-4621-8eeb-519e40b883b9 | 2025-10-21 | Warnings, Adverse reactions | 1300791 |
| MIRABEGRON | MIRABEGRON | Bryant Ranch Prepack | 2965e083-b678-43b9-8e13-2efddc0daad0 | 2025-09-26 | Warnings, Adverse reactions | 1300791 |
| MIRABEGRON | MIRABEGRON | Bryant Ranch Prepack | 3bd73250-2b31-4b22-983b-15119846e697 | 2025-09-26 | Warnings, Adverse reactions | 1300791 |
| Mirabegron | MIRABEGRON | Zydus Lifesciences Limited | 461b2b94-205a-4860-9cb4-d30267ada9df | 2024-10-09 | Warnings, Adverse reactions | 1300791 |
| Mirabegron | MIRABEGRON | Zydus Pharmaceuticals (USA) Inc. | 2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 | 2024-10-09 | Warnings, Adverse reactions | 1300791 |
| Myrbetriq | MIRABEGRON | Astellas Pharma US, Inc. | ba9e9e15-e666-4c56-9271-2e24739cfa2d | 2024-08-01 | Warnings, Adverse reactions | 1300791 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2965e083-b678-43b9-8e13-2efddc0daad0 | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| 3bd73250-2b31-4b22-983b-15119846e697 | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 100 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20250926 |
| d22d3d12-8466-46db-bc19-d13e87c6115c | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 19 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251224 |
| ba9e9e15-e666-4c56-9271-2e24739cfa2d | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 17 | These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012 | 20240801 |
| e597023d-6dcc-4d9e-8ce0-2d28a5d862f3 | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 4 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260326 |
| 2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| 461b2b94-205a-4860-9cb4-d30267ada9df | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20241009 |
| b71b939e-8cb1-492c-8311-28f75dc4c682 | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20260427 |
| 98247602-29b9-4621-8eeb-519e40b883b9 | mirabegron 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 25 MG Extended Release Oral Tablet [SCD] · mirabegron 25 MG 24 HR Release Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012 | 20251021 |